Immunomedics CEO DeLuccia departs

August 4, 1999

Radiopharmaceutical firm Immunomedics of Morris Plains, NJ, in June announced the resignation of Robert DeLuccia, the company’s president, CEO, and director. DeLuccia began his tenure at Immunomedics in June 1998, when he took over duties previously

Radiopharmaceutical firm Immunomedics of Morris Plains, NJ, in June announced the resignation of Robert DeLuccia, the company’s president, CEO, and director. DeLuccia began his tenure at Immunomedics in June 1998, when he took over duties previously handled by the company’s founder, Dr. David Goldenberg (SCAN 6/10/98). Dr. Goldenberg will resume the position of CEO, according to the company.

In other Immunomedics management moves, Philippe Barzin, general manager of Immunomedics Europe, will relocate to the company’s U.S. headquarters and assume the post of vice president for global marketing and business development.